Similar articles

• Selective depletion of noradrenaline: a proposed mechanism of the adrenergic neurone-blocking action of bretylium.

  Abbs ET, Robertson MI. Abbs ET, et al. Br J Pharmacol. 1970 Apr;38(4):776-91. doi: 10.1111/j.1476-5381.1970.tb09887.x. Br J Pharmacol. 1970. PMID: 5441790 Free PMC article.
• Antagonism by (+)-amphetamine of the inhibition of [3H]-noradrenaline overflow obtained by alpha-adrenoceptor agonists or bretylium in the perfused cat spleen [proceedings].

  Dubocovich ML, Langer SZ, Moret C. Dubocovich ML, et al. Br J Pharmacol. 1979 Jul;66(3):460P-461P. Br J Pharmacol. 1979. PMID: 43177 Free PMC article. No abstract available.
• Peripheral noradrenaline and adrenergic transmission in the rat.

  Spriggs TL. Spriggs TL. Br J Pharmacol Chemother. 1966 Jan;26(1):271-81. doi: 10.1111/j.1476-5381.1966.tb01830.x. Br J Pharmacol Chemother. 1966. PMID: 5919511 Free PMC article. No abstract available.
• The effects of bretylium on C fibre excitation and noradrenaline release by acetylcholine and electrical stimulation.

  Davey MJ, Hayden ML, Scholfield PC. Davey MJ, et al. Br J Pharmacol. 1968 Oct;34(2):377-87. doi: 10.1111/j.1476-5381.1968.tb07059.x. Br J Pharmacol. 1968. PMID: 5687592 Free PMC article.
• Reversal by amphetamine of the protective effect of bretylium on reserpine-induced depletion of noradrenaline.

  Chang CC. Chang CC. J Pharm Pharmacol. 1965 Dec;17(12):818-20. doi: 10.1111/j.2042-7158.1965.tb07614.x. J Pharm Pharmacol. 1965. PMID: 4379763 No abstract available.